Skip to main content
SpringerLink
Log in

Facilitating Optimal Care of Acute Coronary, Cerebrovascular and Peripheral Vascular Syndromes in the Emergency Department: The Role of Oral Antiplatelet Therapy

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

The benefits of aspirin use in the emergent care of MI and stroke have been well established. Recent studies have further demonstrated the importance of antiplatelet therapy in the acute setting, primarily with the use of intravenous glycoprotein IIb/IIIa receptor inhibitors. Aspirin and the thienopyridines (ticlopidine and clopidogrel) are oral antiplatelet agents that interfere with platelet activation in complementary, but separate pathways. Combination therapy of clopidogrel and aspirin has demonstrated benefit for the management of acute coronary syndromes, ischemic cerebrovascular disease and peripheral vascular disease in several large trials [1,2]. This article reviews the pathophysiology of platelet activation, landmark trials on oral antiplatelet agents, and the current recommendation for the use of oral antiplatelet agents in the emergency department

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bertrand ME, Rupprecht HJ, Urban P, Gershlick AH, Investigators.Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 2000;102:624–629.

    Google Scholar 

  2. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494–502.

    Google Scholar 

  3. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. Bmj 1994;308:81–106.

    Google Scholar 

  4. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group. Lancet 1990;336:827–830.

  5. Lewis HD, Jr., Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl J Med 1983;309:396–403.

    Google Scholar 

  6. CAPTURE Investigators. Randomized placebo controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study. Lancet 1997;349:1429–1435.

    Google Scholar 

  7. EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl JMed 1997;336:1689–1696.

    Google Scholar 

  8. PRISM Investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina.N Engl J Med 1998;338:1498–1505.

    Google Scholar 

  9. PRISM-PLUS Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998;338:1488–1497.

    Google Scholar 

  10. PURSUIT Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med 1998;339:436–443.

    Google Scholar 

  11. RESTORE Investigators. Effects of platelet glycoprotein IIb/IIIa bolckade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 1997;96:1445–1453.

    Google Scholar 

  12. EPISTENT Investigators. Randomized placebo-controlled and balloon angioplasty controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. Lancet 1998;352:87–92.

    Google Scholar 

  13. Theroux P, Fuster V. Acute coronary syndromes: Unstable angina and non-Q-wavemyocardial infarction. Circulation 1998;97:1195–1206.

    Google Scholar 

  14. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. J Am Coll Cardiol 1988;12:3A–13A.

    Google Scholar 

  15. Patrono C, Coller B, Dalen JE, et al. Platelet-active drugs: The relationships among dose, effectiveness, and side effects. Chest 2001;119:39S–63S.

    Google Scholar 

  16. CAPRIE Investigators. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348:1329–1339.

    Google Scholar 

  17. Savi P, Nurden P, Nurden AT, et al. Clopidogrel: A review of its mechanism of action. Platelets 1998;9:251–255.

    Google Scholar 

  18. Cadroy Y, Bossavy JP, Thalamas C, Sagnard L, Sakariassen K, Boneu B. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Circulation 2000;101:2823–2828.

    Google Scholar 

  19. Gent M. Benefit of Clopidogrel in patients with coronary disease. Circulation 1997;96:I–467 (abstract).

    Google Scholar 

  20. Schomig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084–1089.

    Google Scholar 

  21. Bertrand ME, Legrand V, Boland J, et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study. Circulation 1998;98:1597–1603.

    Google Scholar 

  22. Makkar RR, Eigler NL, Kaul S, et al. Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis. Eur Heart J 1998;19:1538–1546.

    Google Scholar 

  23. Harker LA, Marzec UM, Kelly AB, et al. Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates. Circulation 1998;98:2461–2469.

    Google Scholar 

  24. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 2001;358:527–533.

    Google Scholar 

  25. Schafer AI. Antiplatelet therapy. Am JMed 1996;101:199–209.

    Google Scholar 

  26. Schafer AL. Pharmacodynamics of Oral Antiplatelet Agents. In: Smith TW, ed. Cardiovascular Therapeutics. Philadelphia, PA: W.B. Saunders, 1996:Chapter 27.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA, 01655, USA

    Gregory A. Volturo & Richard V. Aghababian

Authors
  1. Gregory A. Volturo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard V. Aghababian
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Volturo, G.A., Aghababian, R.V. Facilitating Optimal Care of Acute Coronary, Cerebrovascular and Peripheral Vascular Syndromes in the Emergency Department: The Role of Oral Antiplatelet Therapy. J Thromb Thrombolysis 17, 29–34 (2004). https://doi.org/10.1023/B:THRO.0000036026.86674.c8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:THRO.0000036026.86674.c8

Search

Navigation